Research and treatment approaches to depression
The DOI matches its Crossref record; 104 of the 104 references it cites were found in a registry or an index.
Abstract
Depression is a major cause of disability worldwide, but we know little about the underlying fundamental biology. Research is hindered by the difficulties of modelling a disorder of higher cognitive functions in animals. Depression can be understood as the interaction of genetic susceptibility and environmental factors; however, current classifications are purely descriptive. The complexity of this field is best approached by rigorous explorations of known candidate systems in conjunction with the use of genomic tools to discover new targets for antidepressants and to predict therapeutic outcomes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Recent studies using PET imaging 87 as well as analyses of post-mortem brain tissue 88 have indicated neuroinflammation and microglial activation in the central nervous systems of patients with MDD.”
From Major depressive disorder (2016) · cites this paper as [87]
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. (2013) · Encyclopedia of Social Work · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,519
Learned helplessness in humans: Critique and reformulation.
Abramson, L. Y., Seligman, M. E., & Teasdale, J. D. (1978) · Journal of Abnormal Psychology · doi:10.1037//0021-843x.87.1.49 · Cited by 7,121
(1996) · Cited by 6,884
Lesch, K.-P., Bengel, D., Heils, A., Sabol, S. Z., Greenberg, B. D., Petri, S., Benjamin, J., Müller, C. R., Hamer, D. H., & Murphy, D. L. (1996) · Science · doi:10.1126/science.274.5292.1527 · Cited by 5,162 · cited 1×
“have identified a functional polymorphism in the upstream regulatory region of the serotonin transporter gene that affects transcriptional efficienc”
BackgroundA Syndrome produced by Diverse Nocuous Agents
SELYE, H. (1936) · Nature · doi:10.1038/138032a0 · Cited by 3,903
Genetic Epidemiology of Major Depression: Review and Meta-Analysis
Sullivan, P. F., Neale, M. C., & Kendler, K. S. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.10.1552 · Cited by 3,431 · cited 1×
“Major depression has an estimated heritability of 31–42%, which is much lower than the 70% heritability estimated for schizophrenia and bipolar disorde”
BackgroundGenetic Dissection of Complex Traits
Lander, E. S., & Schork, N. J. (1994) · Science · doi:10.1126/science.8091226 · Cited by 3,413
The Concepts of Stress and Stress System Disorders: Overview of Physical and Behavioral Homeostasis
Chrousos, G. P. (1992) · JAMA · doi:10.1001/jama.1992.03480090092034 · Cited by 2,689
Cross-national epidemiology of major depression and bipolar disorder
Weissman, M. M. (1996) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1996.03540040037030 · Cited by 2,302 · cited 1×
“A detailed and well-controlled cross-national epidemiological study examined lifetime rates of depression in ten countrie”
BackgroundExcess mortality of mental disorder
Harris, C., & Barraclough, B. (1998) · British Journal of Psychiatry · doi:10.1192/bjp.173.1.11 · Cited by 1,881 · cited 1×
“Depressed patients have an increased risk of premature death when compared with control subject”
Background
Research works printed but not linked: 1
- Nobel Foundation. Nobel Lectures — Physiology or Medicine, 1901–1970 (Elsevier, Amsterdam, 1970).
Cited by
Items 501–600 of 674
Chronic fluoxetine treatment increases daytime melatonin synthesis in the rodent
Reierson, Wong, M., Licinio, J., & Mastronardi (2009) · Clinical Pharmacology Advances and Applications · doi:10.2147/cpaa.s7157 · Cited by 4
“neuroendocrine regulation are manifested as clinical symptoms in this chronic, highly disabling disorder.(1) Clinical symptoms point to several brain areas of relevance to MDD pathophysiology including the pineal gland, HPA axis (hypothalamus, pituitary, adrenal glands), prefrontal cortex, and hippocampus.”
Self-citationCell-based therapies for disorders of the CNS
Lazic, S. E., & Barker, R. A. (2005) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.15.10.1361 · Cited by 4
Mishra, S., Vk, K., & Kumar, V. (2008) · Cited by 3
Examining the Impacts of Wife Abuse and Child Abuse on Saudi Women’s Mental and Physical health
Alhalal, E. (2016) · Scholarship@Western (Western University) · Cited by 3
Qiao, W., Sun, Y., Meng, F., Chen, Z., Zhang, Q., Zhou, W., & Qin, X. (2013) · Pharmacologia · doi:10.5567/pharmacologia.2013.634.640 · Cited by 3
de Oliveira, R. L., Voss, G. T., Paltian, J. J., Pinz, M. P., Torres, M. L. C. P., Moreira, M. P., Dilelio, M. C., Silveira, C. C., Wilhelm, E. A., & Luchese, C. (2019) · Metabolic Brain Disease · doi:10.1007/s11011-019-00436-x · Cited by 5
Schläpfer, T. E. (2007) · Nervenheilkunde · doi:10.1055/s-0038-1626946 · Cited by 3
Wang, L., Jiang, B., Ji, X., Tu, J., Lu, F., Yang, C., Zhong, X., Wang, L., Xiao, C., Yi, F., et al. (2025) · Neurobiology of Disease · doi:10.1016/j.nbd.2025.106898 · Cited by 2
“…dimorphic brain region and a critical neuroendocrine center within the HPA axis, shows significant neuronal and molecular alterations in anxiodepressive models and patients, highlighting its close association with the pathogenesis of anx-iodepression (Gong et al., 2021; Wong and Licinio, 2001).”
Zorina, K. A., Kriveckiy, A. A., Karmanov, V. S., & Savostyanov, A. N. (2025) · Vavilov Journal of Genetics and Breeding · doi:10.18699/vjgb-25-117 · Cited by 2
History and Epidemiology of Depression
Wong, M. (2005) · Wiley eBooks · doi:10.1002/9783527619672.ch26 · Cited by 3
Self-citationPrietsch, R. D. F. (2015) · Revista Eletrônica de Farmácia · doi:10.5216/ref.v12i2.25350 · Cited by 2
Critiquing the Critique: Resisting Commonplace Criticisms of Antidepressants in Online Platforms
Sthamann, E., & McMullen, L. M. (2021) · Qualitative Health Research · doi:10.1177/10497323211040768 · Cited by 2
“For example, Wong and Licinio (2001) wrote that there are “serious gaps and limitations in the monoamine hypothesis” (p. 347) and pointed to research indicating that there is increased (not decreased) norepinephrine output in depression and that antidepressant drugs affect neurotransmitters within…”
BackgroundScreening In silico Antidepressant Activity of Aqueous Extract of Leaves of Rumex acetosa L.
Shareef, M. M., & Bhavya, E. (2023) · Trends in Sciences · doi:10.48048/tis.2023.4664 · Cited by 2
A Comprehensive Review on the Neuropharmacological Effects of Antidepressants in Various Prospects
Varshney, S., Alam, A., Kaur, A., & Sharma, S. (2023) · Current Psychopharmacologye · doi:10.2174/2211556011666230707122341 · Cited by 3
Nag, K., Solanki, D., Peddha, M. S., Mehdi, S., Logesh, R., Roohi, T. F., Kinattingal, N., & Shakeel, F. (2024) · Neuroscience Letters · doi:10.1016/j.neulet.2024.137844 · Cited by 2
Perceived stress, risk factors and prognostic monitoring loci for the development of depression
Li, X., Zhao, W., Wei, Y.-H., Zhang, X.-S., Zhu, Y., & Li, X. (2025) · World Journal of Psychiatry · doi:10.5498/wjp.v15.i6.105222 · Cited by 2
Deep Brain Stimulation for Highly Refractory Depression
Greenberg, B. D. (2009) · Elsevier eBooks · doi:10.1016/b978-0-12-374248-3.00057-4 · Cited by 2
Molecular genetics of affective disorders
Oswald, P., Souery, D., & Mendlewicz, J. (2003) · Current Opinion in Psychiatry · doi:10.1097/00001504-200304002-00010 · Cited by 2
Dissecting a Model of Depressive-Related Phenotype and Antidepressant Effects in 129S2/SvPas Mice
Diaz, S. L., & Maroteaux, L. (2014) · Neuromethods · doi:10.1007/978-1-4939-2187-4_4 · Cited by 2
Antidepressant‐Like Activity of Agomelatine in the Mouse Unpredictable Chronic Mild Stress Model
Mutlu, O., Gümüşlü, E., Ulak, G., Celikyurt, I. K., Akar, F., Bektaş, E., ŞAHİN, T. D., Kır, H. M., Musul, M. M., & Erden, F. (2013) · Drug Development Research · doi:10.1002/ddr.21064 · Cited by 5
“Despite the improved tolerability of newer antidepressants, for example, selective serotonin reuptake inhibitors (SSRIs) [Anderson, 2000; Sonawalla and Fava, 2001], which act through the monoaminergic system, the therapeutic response develops slowly (3–4 weeks), side effects often occur, and a significant percentage (…”
BackgroundKhosravian, M., Nikpour, P., Emadi‐Baygi, M., Soleimanpour, A., & Moghadam, F. Y. (2020) · Archives of Neuroscience · doi:10.5812/ans.102247 · Cited by 2
Les transporteurs de cations organiques, nouvelles cibles thérapeutiques contre la dépression
Gautron, S., & Pietrancosta, N. (2020) · médecine/sciences · doi:10.1051/medsci/2020143 · Cited by 2
Guanine-Based Purines as an Innovative Target to Treat Major Depressive Disorder
Almeida, R. F., Ferreira, T. P., David, C. V. C., Silva, P. C. A. E., dos Santos, S. A., Rodrigues, A. L. S., & Elisabetsky, E. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.652130 · Cited by 3
Montero, A., Fernández, B., & Romero, L. I. (2007) · Wiley eBooks · doi:10.1002/9783527619337.ch4 · Cited by 2
Rang, H. P., Dale, M. M., Ritter, J., & Flower, R. (2007) · Elsevier eBooks · doi:10.1016/b978-0-443-06911-6.50044-x · Cited by 6
Neurotrophins and neuronal plasticity in the action of antidepressants and morphine
Sairanen, M. (2007) · Helda - University of Helsinki Institutional Repository · Cited by 2
Performance Under Pressure: Examination of Relevant Neurobiological and Genetic Influence
Goodman, R. N. (2008) · University Libraries (University of Maryland) · Cited by 2
Consideration of Antidepressants in Patients with Chronic Pain
Moon, D. E. (2004) · The Korean journal of pain · doi:10.3344/kjp.2004.17.s.s54 · Cited by 2
Brain TrkB neurotrophin receptor as a target for antidepressant treatments
Rantamäki, T. (2006) · Helda - University of Helsinki Institutional Repository · Cited by 5
Deep Brain Stimulation in Depression: Background, Progress, and Key Issues
Greenberg, B. D. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-360-8_25 · Cited by 2
Zhao, Z. (2008) · The Research Repository @ WVU (West Virginia University) · doi:10.33915/etd.2697 · Cited by 2
Ozaki, N. (2006) · Wiley eBooks · doi:10.1038/npg.els.0005162 · Cited by 2
Memon, F. S., & Sheikh, A. F. (2022) · Precision Medicine Communications · doi:10.55627/pmc.002.01.0044 · Cited by 1
Wang, G., Tao, Y., Wu, N., Li, R., Lee, W. H., Cao, Z., Yan, X., Chen, B., & Wang, G. (2025) · IEEE Transactions on Affective Computing · doi:10.1109/taffc.2025.3602185 · Cited by 1
“D EPRESSION is one of the most common mental disorders that can significantly impact an individual’s quality of life, manifesting as disinterest in daily activities, anhedonia, pessimism, guilt, and in severe cases, suicidal ideation [1].”
Feng, Y., Guan, Z., Che, C., & Liang, L. (2026) · Biomedical Signal Processing and Control · doi:10.1016/j.bspc.2026.109604 · Cited by 1
The nature of depression and the biomedical model: ten questions in search of an answer
Fountoulakis, K. Ν. (2026) · Translational Psychiatry · doi:10.1038/s41398-026-03943-5 · Cited by 1
“Gene-environment interactions are currently a hot topic and attract increasing attention [61 – 64], but the enduring results are impressively poor.”
Attenuation of apomorphine induced behavioral sensitization in rats pre-treated with tryptophan
Farhan, M., & Haleem, D. J. (2018) · Pakistan Journal of Pharmaceutical Sciences · doi:10.36721/pjps/31/6/01.11.2018/4157/2561-2567 · Cited by 1
Sanna, M. D., Ghelardini, C., & Galeotti, N. (2015) · SM Journal of Depression Research and Treatment · doi:10.36876/smjdrt.1007 · Cited by 1
“Although these antidepressant agents can produce a rapid increase of serotonin (5-HT) and/or Noradrenaline (NA) at synaptic levels, it usually takes at least 3 to 4 weeks to obtain an appreciable clinical effect [1,2].”
BackgroundDepresyon Patofizyolojisinde Hipokampusun Rolü
Eker, M. C., & Eker, Ö. D. (2014) · Psikiyatride Guncel Yaklasimlar - Current Approaches in Psychiatry · doi:10.18863/pskguncel.133469 · Cited by 1
“İlk bölüm cornu ammonis[1-4] bölgelerinin olușturduğu esas hippokampus (proper) diğer bölümler ise dentat girus ve subiculumdur.”
Depresión inducida por estrés emocional o ¿estado de ‘agotamiento nervioso’?
León‐Barúa, R. (2007) · Boletín de la Sociedad Peruana de Medicina Interna/Revista de la Sociedad Peruana de Medicina Interna · doi:10.36393/spmi.v20i4.275 · Cited by 7
Vanvossen, A. C. (2012) · Cited by 1
Immunopathology of the Nervous System
Remick, A. K., Pershing, M. L., Papenfuss, T. L., Lanigan, L. G., Beck, M. J., & Toot, J. (2017) · Molecular and integrative toxicology · doi:10.1007/978-3-319-47385-7_5 · Cited by 1
Ahmed, E., Tawfik, M. K., Essawy, S. S., Ahmed, A., & Hermans, E. (2018) · Egyptian Journal of Basic and Clinical Pharmacology · doi:10.11131/2018/101383 · Cited by 1
“Although it produces a rapid increase in extracellular levels of serotonin and noradrenaline, the onset of an appreciable clinical effect usually takes at least 3 to 4 weeks [55] suggesting that slow neurochemical and structural changes take place within the limbic target areas of monoaminergic projections [17].”
BackgroundVittalrao, A. M., Agarwal, S., Kumari, M., & Poojar, B. (2019) · Biomedical & Pharmacology Journal · doi:10.13005/bpj/1777 · Cited by 1
IMPACT OF EARLY LIFE STRESS ON ANTI-DEPRESSANT SENSITIVITY
Vokina, V. A. (2021) · Ulyanovsk Medico-biological Journal · doi:10.34014/2227-1848-2021-1-123-132 · Cited by 1
Bear, M. F., Connors, B. W., & Paradiso, M. A. (2018) · Springer eBooks · doi:10.1007/978-3-662-57263-4_22 · Cited by 1
Bear, M. F., Connors, B. W., & Paradiso, M. A. (2009) · Spektrum Akademischer Verlag eBooks · doi:10.1007/978-3-8274-2228-6_23 · Cited by 1
Sousa, L. J. D. R., de Paula, C. A., & de Almeida, M. E. F. (2022) · Research Society and Development · doi:10.33448/rsd-v11i7.29445 · Cited by 8
Viral vector-mediated expressions of venom peptides as novel gene therapy for anxiety and depression
Okada, M., & Ortíz, E. (2022) · Medical Hypotheses · doi:10.1016/j.mehy.2022.110910 · Cited by 1
Antidepressant effect of new coumarin derivatives
Daliev, B. B., Klimenko, D. I., Karpova, I. V., Myznikov, L. V., Бычков, Э. Р., Aa, L., & Shabanov, P. D. (2024) · Reviews on Clinical Pharmacology and Drug Therapy · doi:10.17816/rcf623295 · Cited by 1
Avaliação da Atividade Antidepressiva e Ansiolítica do Óleo Essencial de Rosmarinus officinalis L.
de Lima, V. M. (2010) · Aleph UCLA Undergraduate Research Journal for the Humanities and Social Sciences · Cited by 2
Die Neurobiologie der Depression - im Fokus: Imaging Genetics
Pezawas, L., Moser, U., & Kasper, S. F. (2007) · Journal für Kardiologie (Krause & Pachernegg GmbH) · Cited by 2
Sequence and function in pharmacogenomics
Licinio, J., & Wong, M.-L. (2003) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500185 · Cited by 1
Self-citationBosaipo, N. B. (2016) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.17.2016.tde-26082016-153726 · Cited by 4
Jones, R. (2002) · Nature reviews. Neuroscience · doi:10.1038/nrn862 · Cited by 1
Bhattacharjee, S., Roy, S., Das, A., Paul, S. C., & Debi, S. R. (2019) · International Journal of Pharmaceutical Sciences and Research · doi:10.13040/ijpsr.0975-8232.10(5).2619-27 · Cited by 1
Mendez‐David, I. (2013) · theses.fr (ABES) · doi:10.70675/3b74ce4cz68acz4446zbe46zb1542d4e9391 · Cited by 1
Le récepteur 3 de la neurotensine/Sortiline dans la régulation de l’état dépressif
Moréno, S. (2017) · theses.fr (ABES) · doi:10.70675/bd5432bcz3426z4e54z9081zd99b2eb3f712 · Cited by 1
Busnello, J. V. (2006) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Proteome Effects of Antidepressant Medications
Carboni, L., Piubelli, C., & Domenici, E. (2010) · Advances in neurobiology · doi:10.1007/978-1-4419-7197-5_15
“Major depression is a heterogeneous disease with no established mechanism; a number of different hypothesis have been formulated to understand its pathophysiological bases (Belmaker & Agam, 2008; Manji, Drevets, & Charney, 2001; Nestler et al., 2002, Wong & Licinio, 2001 ).”
BackgroundPharmacogenetics and Pharmacogenomics of Antidepressant Drug Action
Wong, M. (2005) · Wiley eBooks · doi:10.1002/9783527619672.ch34
Self-citationYochiy, A. (2010) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.47.2010.tde-26072010-143609
On antidepressant effects of running and SSRI : Focus on hippocampus and striatal dopamine pathways
Bjørnebekk, A. (2007) · Figshare · Cited by 2
A.P., O., T.S, Á., Neto, S., & W.J.J., F. (2012) · Revista Eletrônica da Faculdade de Ceres · doi:10.36607/refacer.v1i1.3401
Issues and Clues in the Pharmacological Treatment of Mood Disorders
Jollant, F., Ionita, A., & Courtet, P. (2010) · Wiley eBooks · doi:10.1002/9780470749180.ch6
Introductory and Basic Aspects
Romero, L. I., Montero, A., Fernández, B., & Vela, J. M. (2007) · Wiley eBooks · doi:10.1002/9783527619337.ch1
Mediators of synaptic activity in anxiety- and depression-related behaviors
Kiselycznyk, C. (2012) · Figshare
Tokumoto, A. M. (2010) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.59.2010.tde-22032010-002457 · Cited by 1
Maduración neuronal en el giro dentado del hipocampo adulto
Piatti, V. C. (2009)
Behavioural, neurochemical and neuroendocrine effects of predator stress in mice
Beekman, M. (2004) · doi:10.5282/edoc.2193 · Cited by 1
Étifoxine : pharmacologie comportementale
Verleye, M. (2008) · L Encéphale · doi:10.1016/s0013-7006(08)71387-3
“La physiopathologie des troubles de l’anxiété est sous-tendue à la fois par des facteurs génétiques à l’origine d’une plus grande vulnérabilité, et par des facteurs environnementaux [6, 27].”
BackgroundEVALUATION OF NEUROPHARMACOLOGICAL ACTIVITIES OF STEPHANIA VENOSA HERB CONSUMPTION IN HEALTHY RATS
Tong-un, T., Phachonpai, W., Muchimapura, S., Wannanon, P., & Wattanathorn, J. (2012) · American Journal of Agricultural and Biological Sciences · doi:10.3844/ajabssp.2012.271.277
Faccin, G. L., Amante, E. R., Tramonte, V. L. C. G., Pinto, M. T., & Wazlawik, E. (2010) · Journal of Medicinal Food · doi:10.1089/jmf.2009.0180
“11 Stress leads to physiological and behavioral changes that may be the basis of several diseases, involving changes in behavior and immunity.”
P.1.003 Inflammatory response in the brain of rats exposed to chronic mild stress
Zecchillo, C., Macchi, F., Molteni, R., Racagni, G., Papp, M., & Riva, M. A. (2013) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(13)70005-1
“which an individual can be exposed in different moments of life [1].”
BackgroundInfluentialKumar, M., Gupta, A. K. D., Bansal, V., Singh, R., & Kumar, V. (2012) · Neurochemical Research · doi:10.1007/s11064-012-0743-z
RetractedModelagem molecular de compostos arilpiperazínicos e suas interações com o receptor 5-HT1A
Weber, K. C. (2008) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.75.2008.tde-05122008-165529
Sherman, B. J. (2012) · doi:10.7916/d8vq38w4 · Cited by 1
“Research on the serotonin transpor er gene 5-HTT has shown that carriers of the short allele are at greater risk for depression and anxiety-related temperamental traits (Pezawas et al., 2005) and anxious temperament has been linked with risk for depression (see Wong & Licinio, 2001).”
BackgroundComunicación y Psicobioquímica
Sánchez, P. T., Sirera, R., Sánchez, J. M., & Camps, C. (2012) · Cited by 3
Veränderungen des Lipoproteinprofils unter kurzzeitiger Mirtazapineinnahme bei gesunden Probanden
Lechner, K. (2013) · doi:10.5282/edoc.15557 · Cited by 1
Jacobson, L. H. (2007) · edoc (University of Basel) · doi:10.5451/unibas-004290851
“…depression disorders are characterised by a broad range of diverse, overlapping symptom clusters (Merikangas et al. 2003) and are classified into numerous categories and subcategories, based mainly on the subjective descriptions of symptoms (Lam et al. 2006; Wong and Licinio 2001) (Table 1 & 2).”
BackgroundInfluentialKuijpers, M. (2010) · Utrecht University Repository (Utrecht University)
ESTUDO DO EFEITO NEUROPROTETOR DA DULOXETINA
Engel, D. F. (2013) · Americanae (AECID Library) · Cited by 1
EFEITO ANTIDEPRESSIVO DA LAMOTRIGINA NO MODELO DE NATAÇÃO FORÇADA MODIFICADO EM RATOS
Consoni, F. T. (2005) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Lutter, M. L. (2011) · Springer eBooks · doi:10.1007/978-1-4419-8390-9_25
Anderson, S. T. (2014) · Maynooth University ePrints and eTheses Archive (Maynooth University)
Wang, X., Sun, H., Wang, S., Xie, G., Gao, S., Sun, X., Wang, Y., & Jiang, N. (2013) · Lecture notes in electrical engineering · doi:10.1007/978-94-007-7618-0_62
Rodrigues, R. (2015) · International Journal of Neurology and Neurotherapy · doi:10.23937/2378-3001/2/1/1015
“In case of depression, the interaction with AD phenotypes trough molecular signaling will accelerate the processes of neuro-degeneration and apoptosis in view of the cortisol cascades, increases of glutamate, Ca2+, oxidative stress and hippocampal atrophy [26-31] as mentioned before (Figure 1), a very short summary sk…”
BackgroundConsequences of traumatic stress in Rwandan genocide
Sektion, M.-N. (2010)
Uso de antidepressivos pela população da cidade de São Paulo
Peluffo, M. P. (2014) · Americanae (AECID Library)
Oliveira‐Giacomelli, Á. (2014)
Transcriptional regulation of FEV, a human serotonin neuron developmental control gene
Krueger, K. C. (2009) · OhioLink ETD Center (Ohio Library and Information Network)
INVESTIGAÇÃO DO POTENCIAL ANTIDEPRESSIVO DE ROSMARINUS OFFICINALIS
Machado, D. G. (2012) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · Cited by 1
Gray, V. (2013) · UC Research Repository (University of Canterbury) · doi:10.26021/8445
Metadata
- Authors
- Wong, M.-L., & Licinio, J.
- Affiliations
- University of California, Los Angeles (US)
- ORCID
- Wong, Ma-Li
- Venue
- Nature Reviews Neuroscience
- Published
- 2001-05
- Volume
- 2
- Issue
- 5
- Pages
- 343-351
- ISSN
- 1471-003X (ISSN-L)
- 1471-0048
- OpenAlex
- W2102343823
- Cited by
- 656
- References
- 104
- Citations by year
- 2026: 5 · 2025: 8 · 2024: 16 · 2023: 22 · 2022: 18 · 2021: 22 · 2020: 14 · 2019: 20 · 2018: 33 · 2017: 29 · 2016: 28 · 2015: 24 · 2014: 39 · 2013: 30 · 2012: 41
- FWCI
- 2.03
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Alliance for Research on Schizophrenia and Depression
- National Institutes of Health
- National Institute of Mental Health
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Keywords
- depression, antidepressant targets, genetic susceptibility, environmental factors, animal models of depression, cognitive impairment, depression classification, genomic tools, therapeutic outcome prediction
- MeSH terms
- Animals, Antidepressive Agents, Brain Chemistry, Depression, Humans, Drug Design, Causality
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.